Chief Medical Officer Stephen Brannan Sells 15,000 Shares of Karuna Therapeutics Inc
Stephen Brannan, Chief Medical Officer of Karuna Therapeutics Inc (NASDAQ:KRTX), has sold 15,000 shares of the company on January 8, 2024, according to a recent SEC Filing. Karuna Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for psychiatric and neurological conditions.
The insider's transaction history indicates that over the past year, the insider has sold a total of 60,000 shares and has not made any purchases of the company's stock. This latest transaction continues the trend of insider sales at Karuna Therapeutics Inc, with a total of 19 insider sells and no insider buys reported over the past year.
On the date of the insider's recent sale, shares of Karuna Therapeutics Inc were trading at $316.81, which places the company's market cap at approximately $11.994 billion.
The insider trends for Karuna Therapeutics Inc suggest a pattern of insider sales over the past year, which may be of interest to investors and analysts monitoring insider behaviors and their potential implications on the company's stock performance.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
